ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
62 hedge funds and large institutions have $7.97M invested in Zynerba Pharmaceuticals, Inc in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
36% less capital invested
Capital invested by funds: $12.5M → $7.97M (-$4.57M)
Holders
62
Holding in Top 10
–
Calls
$68K
Puts
$12K
Top Buyers
| 1 | +$274K | |
| 2 | +$215K | |
| 3 | +$170K | |
| 4 |
Two Sigma Investments
New York
|
+$90K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$87K |
Top Sellers
| 1 | -$397K | |
| 2 | -$242K | |
| 3 | -$138K | |
| 4 |
PCM
Penserra Capital Management
Orinda,
California
|
-$100K |
| 5 |
IEFM
IQ EQ Fund Management
Dublin 2,
Ireland
|
-$78.2K |